PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China flag China · Delayed Price · Currency is CNY
32.85
+2.22 (7.25%)
Nov 5, 2026, 4:00 PM EST

SHE:301230 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
133.7859.1184.52204.3763.64108.44
Short-Term Investments
-4.494.534.966.364.33
Trading Asset Securities
135.68248.98251.77340.7910.650.4
Cash & Short-Term Investments
269.46312.58340.81550.05780.65113.17
Cash Growth
-10.91%-8.29%-38.04%-29.54%589.78%1.71%
Accounts Receivable
153.97151.35101.7986.2587.7492.35
Other Receivables
5.013.383.072.530.020.01
Receivables
158.98154.73104.8688.7887.7692.36
Inventory
66.774.0569.0461.4251.0946.77
Prepaid Expenses
----1.65-
Other Current Assets
47.840.7439.631.0815.3924.91
Total Current Assets
542.94582.1554.32731.32936.53277.21
Property, Plant & Equipment
329.22338.38359.83570.23254.66217.62
Long-Term Investments
83.0533.1720.0810.08-1.9
Other Intangible Assets
9.098.628.498.718.257.94
Long-Term Deferred Tax Assets
53.547.230.8110.292.842.05
Long-Term Deferred Charges
256.02283.08318.97155.3371.0650.62
Other Long-Term Assets
12.8421.5623.931.1927.920.45
Total Assets
1,2871,3141,3161,4871,301557.81

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
56.562.5652.12114.6139.7750.65
Accrued Expenses
43.4546.7834.6532.6134.3431.26
Short-Term Debt
10.0110.0110.0115.9210.0122.34
Current Portion of Leases
23.5925.9920.4118.769.869.09
Current Income Taxes Payable
2.211.020.923.332.217.46
Current Unearned Revenue
9.638.155.114.172.57.01
Other Current Liabilities
9.6517.72.191.812.180.85
Total Current Liabilities
155.05172.21125.4191.22100.87128.67
Long-Term Leases
110.61129.3151.29171.6780.4376.92
Long-Term Unearned Revenue
0.220.220.17---
Long-Term Deferred Tax Liabilities
4.44.163.313.632.510.06
Other Long-Term Liabilities
2.263.983.573.14.563.72
Total Liabilities
272.54309.87283.73369.62188.38209.37

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
180.94139.59139.59107.6276.8757.62
Additional Paid-In Capital
732.04772.93766.81798.77824.13146.08
Retained Earnings
146.32144.84179.32211.15211.97144.07
Treasury Stock
-45.09-53.08-53.08---
Comprehensive Income & Other
-0.09-0.040.06--0.080.66
Shareholders' Equity
1,0141,0041,0331,1181,113348.44
Total Liabilities & Equity
1,2871,3141,3161,4871,301557.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
144.21165.31181.71206.35100.3108.35
Net Cash (Debt)
125.25147.27159.11343.69680.354.82
Net Cash Growth
-1.75%-7.44%-53.71%-49.48%14005.50%-94.56%
Net Cash Per Share
0.680.790.861.904.730.04
Filing Date Shares Outstanding
179.2178.8178.8181.88181.88136.34
Total Common Shares Outstanding
179.2178.8178.8181.88181.88136.34
Working Capital
387.89409.88428.92540.1835.66148.54
Book Value Per Share
5.665.625.786.146.122.56
Tangible Book Value
1,005995.611,0241,1091,105340.5
Tangible Book Value Per Share
5.615.575.736.106.072.50
Buildings
-56.653.8853.8852.5648.86
Machinery
-281.61262.93228.35170.56126.61
Construction In Progress
-7.331.42199.9827.4224.77
Order Backlog
--311.78308.14365.31236.88